The technique of filtration which has constantly been improved over pa
st years makes it possible to obtain highly pure blood products (the r
ate of leukocyte depletion can reach 3 to 5 log). Several study groups
(BEST, PSL) and international commitees of experts have defined a num
ber of standards with which leukocyte depleted blood products must com
ply. Assessment of filration procedures is thus made necessary, it app
lies to the different steps of the filtration procedure: preparation t
echniques of red cell or platelet suspension, priming and rinsing of t
he filter. Likewise a number of parameters have to be checked: filtrat
ion time, temperature, age of suspensions. Moreover quality control pr
ocedures must be implemented, using adapted and validated measuring me
thods (Nageotte hemacytometer, for instance). The parameters to be mon
itored include the number of residual leukocytes, (mean value : 1 x 10
(6) i.e. about 4 WBCs/mul), and the rate of hemoglobin or platelet rec
overy. Any new filtering equipment or material must satisfy strict req
uirements and standards including clinically acceptable limits as part
of the same quality approach. Validation, in this case, consists in d
etermining the maximal leukocyte content which the filter can absorb (
capacity) and the average rate of leukocyte removal (efficacy). The co
nstant monitoring of filtration performance contributes to improving t
he quality of red blood cell or platelet suspensions a nd thus meet cl
inicians' requirements for their patients.